CN Patent

CN107106485A — 甲氨蝶呤制剂

Assigned to Therakind Ltd · Expires 2017-08-29 · 9y expired

What this patent protects

液体药物组合物包含甲氨蝶呤游离酸和缓冲剂，其中组合物的pH的范围为6.5至8.2。还描述了用于制备液体药物组合物的方法。液体药物组合物可用于治疗。

USPTO Abstract

液体药物组合物包含甲氨蝶呤游离酸和缓冲剂，其中组合物的pH的范围为6.5至8.2。还描述了用于制备液体药物组合物的方法。液体药物组合物可用于治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN107106485A
Jurisdiction
CN
Classification
—
Expires
2017-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Therakind Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.